BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36340183)

  • 1. Everolimus-Loaded Reconstituted High-Density Lipoprotein Prepared by a Novel Dual Centrifugation Approach for Anti-Atherosclerotic Therapy.
    Deuringer B; Härdtner C; Krebs K; Thomann R; Holzer M; Hilgendorf I; Süss R
    Int J Nanomedicine; 2022; 17():5081-5097. PubMed ID: 36340183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein.
    Rong T; Wei B; Ao M; Zhao H; Li Y; Zhang Y; Qin Y; Zhou J; Zhou F; Chen Y
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Lovastatin-Loaded Spherical Reconstituted High Density Lipoprotein for Efficient and Safe Anti-Atherosclerotic Therapy.
    Jiang C; Qi Z; Tang Y; Jia H; Li Z; Zhang W; Liu J
    Mol Pharm; 2019 Jul; 16(7):3284-3291. PubMed ID: 31117743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells.
    He J; Yang Y; Zhou X; Zhang W; Liu J
    J Mater Chem B; 2020 Feb; 8(7):1496-1506. PubMed ID: 31999290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
    Zhang W; Li J; Liu J; Wu Z; Xu Y; Wang J
    Pharmazie; 2012 Apr; 67(4):324-30. PubMed ID: 22570939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytic recycling as cellular trafficking fate of simvastatin-loaded discoidal reconstituted high-density lipoprotein to coordinate cholesterol efflux and drug influx.
    Qi Z; Jiang C; Gao H; Wang Y; Zhang Q; Zhang W; Liu J
    Nanomedicine; 2021 Feb; 32():102323. PubMed ID: 33186693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anchoring β-CD on simvastatin-loaded rHDL for selective cholesterol crystals dissolution and enhanced anti-inflammatory effects in macrophage/foam cells.
    He J; Zhou X; Xu F; He H; Ma S; Liu X; Zhang M; Zhang W; Liu J
    Eur J Pharm Biopharm; 2022 May; 174():144-154. PubMed ID: 35447349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization.
    Zhang Q; He J; Xu F; Huang X; Wang Y; Zhang W; Liu J
    Biomater Sci; 2021 Sep; 9(18):6153-6168. PubMed ID: 34346410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
    Zhang WL; Xiao Y; Liu JP; Wu ZM; Gu X; Xu YM; Lu H
    Int J Pharm; 2011 Oct; 419(1-2):314-21. PubMed ID: 21835236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating the Size of Simvastatin-loaded Discoidal Reconstituted Highdensity Lipoprotein: Preparation, Characterization, and Investigation of Cellular Cholesterol Efflux.
    Huang X; Gao H; Zhang W; Liu J; Zhang Q
    Curr Drug Deliv; 2023; 20(5):629-641. PubMed ID: 35430991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.
    Zhao Y; Jiang C; He J; Guo Q; Lu J; Yang Y; Zhang W; Liu J
    Bioconjug Chem; 2017 Feb; 28(2):438-448. PubMed ID: 28004910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis.
    Wang Y; Gao H; Huang X; Chen Z; Kang P; Zhou Y; Qin D; Zhang W; Liu J
    Carbohydr Polym; 2022 Sep; 292():119632. PubMed ID: 35725197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
    Calabresi L; Canavesi M; Bernini F; Franceschini G
    Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.
    Zhang W; He H; Liu J; Wang J; Zhang S; Zhang S; Wu Z
    Biomaterials; 2013 Jan; 34(1):306-19. PubMed ID: 23069716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle.
    Jiang C; Zhao Y; Yang Y; He J; Zhang W; Liu J
    Mol Pharm; 2018 Mar; 15(3):1017-1027. PubMed ID: 29382194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
    Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
    Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.
    He H; Liu L; Bai H; Wang J; Zhang Y; Zhang W; Zhang M; Wu Z; Liu J
    Pharm Res; 2014 Jul; 31(7):1689-709. PubMed ID: 24449440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.
    He H; Zhang M; Liu L; Zhang S; Liu J; Zhang W
    Pharm Res; 2015 Oct; 32(10):3415-31. PubMed ID: 26040661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.